tag contract-manufacturing 
Pharmaceutical Technology
FEBRUARY 10, 2023
On November 22, 2022, the FDA approved CSL Behring’s Hemgenix (etranacogene dezaparvovec), the first gene therapy treatment for hemophilia B, with a staggering manufacturer price of $3.5 This is not the first treatment to come with a high price tag.
pharmaphorum
JANUARY 21, 2022
This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
DECEMBER 20, 2022
Oxybutynin is an antispasmodic and anticholinergic drug, which relaxes smooth muscles in the bladder by blocking acetylcholine, the chemical that signals muscles to contract. . As a generic, oxybutynin manufacturers rarely offer patient assistance programs or rebates. Fortunately, a few strategies can help bring down the cost.
pharmaphorum
NOVEMBER 19, 2021
This is due to their first-to-market status, their efficacy and safety profiles and manufacturing success. Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. It’s understood the prices have increased in new supply contracts, possibly by as much as a quarter. Pfizer is understood to have charged $19.50
Viseven
SEPTEMBER 14, 2023
Outlining contract terms. Climate change is another factor, potentially disrupting supplies and contributing to hefty price tags. Restricted tender : Suppliers must go through the prequalification process to prove their past supplier performance, manufacturing practices, and financial viability. Determining drug quantities.
pharmaphorum
JUNE 15, 2021
The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. But there is a silver lining.
Pharmaceutical Technology
JANUARY 27, 2023
Unlike other contracts, a refund for Cablivi depends on individual clinical outcomes compared to more commonly used population-based outcomes. Over the last few years, as price tags for drugs have continuously increased, the popularity of risk sharing agreements has been increasing at a rate of 24% annual average growth.
Expert insights. Personalized for you.
105 
Let's personalize your content